This guide to the Hip Fracture Clinical Care Standard (2023) explains what each quality statement means for consumers, and what you can do to have an active role in your own care.

The standard contains eight quality statements that describe the health care you should receive to support the correct use of psychotropic medicines. This fact sheet explains each quality statement and what it means for you.  

This is an easy read document about the standard. The standard is to help everyone know how and when to use psychotropic medicines.

A presentation from Professor Jenny May AM on the Challenges of quality use of medicines in rural settings.

A presentation from Professor Jennifer Martin on a Clinician’s perspective on managing medicines for an ageing population. 

A presentation from Ms Alice Nugent on Digital tools for medicines management in Aboriginal Community Controlled Health Organisations.

A presentation by Mr Bronte Parkin on Polypharmacy Consumer Perspective.

This issue includes items on new resources to guide post-sepsis care and survivor support, open disclosure, shared decision making, peripheral intravenous catheters, and more. Along with the latest from Healthcare Papers,  BMJ Quality & Safety, International Journal for Quality in Health Care and Health Expectations. Also included...

This resource accompanies the Hip Fracture Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.

The quality statements for the Hip Fracture Clinical Care Standard are based on best available evidence and guideline recommendations at the time of development. This summary describes the relevance of each evidence source to the quality statements.